Remote Jobs at Aurion Biotech

Aurion Biotech

51 - 200 employees

Founded 2022

🧬 Biotechnology

💊 Pharmaceuticals

💰 $120M Venture Round - Aurion Biotechnologies on 2022-04

Biotechnology • Pharmaceuticals

Aurion Biotech is a clinical-stage company developing first-in-class regenerative cell therapies to restore vision by treating corneal endothelial disease and other causes of blindness. The company focuses on manufacturing-scale cell therapy platforms, using human donor corneal endothelial cells combined with supportive compounds (e. g. , rho-kinase inhibitor) to repopulate the corneal endothelium, reduce reliance on donor tissue, and enable less-invasive alternatives to graft-based keratoplasty. Aurion conducts global clinical trials, holds FDA Breakthrough Therapy and RMAT designations for its lead product AURN001, and aims to expand access to advanced ophthalmic care worldwide.